mild symptoms; bruising at the injection site; fever of 100.0; She did get the pink splotches again, but it wasn't bad; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD22-025396 (Moderna), MOD22-019461 (Moderna).  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 4 (booster), single (Lot number: GJ3277) for covid-19 immunisation. The patient's relevant medical history included: "pain at the bottom of her left ear" (unspecified if ongoing), notes: She had pain at the bottom of her left ear that was traveling to her arm; "Nickel - skin reaction" (unspecified if ongoing), notes: Allergies (medications, food and other products): Nickel - skin reaction. There were no concomitant medications. Vaccination history included: moderna covid-19 vaccine (Dose Number: 3, Manufacturer: Moderna, Lot number: 939903, Expiration date: 18JAN2022, Dose: 0.25 mL, Anatomical location: left arm, On 29Oct2021 at 4:19 PM, her body started to feel inflamed), administration date: 28Oct2021, for COVID-19 immunization, reaction(s): "her body started to feel inflamed", "She woke up and her heart felt tight", "she was having heartburn", "her back muscles felt tight", "She also felt a little dizzy", "nauseous", "Her arms, face, and chest felt swollen", "Her arms, face, and chest felt swollen", "Her arms, face, and chest felt swollen", "she started having swelling under her left arm", "she woke up with her arm swollen and painful", "she still felt tired", "she took her temperature and it was at 100.0", "she still had a very sore left arm", "Her skin was warm to the touch", "Her injection site was swollen, warm, firm, and pink", "Her injection site was swollen, warm, firm, and pink", "She could still see the "pink splotch" at the injection site. It was itchy, just a red area of skin", "She could still see the "pink splotch" at the injection site. It was itchy, just a red area of skin.", "Her blood pressure was 132/87", "heart rate was 86 beats per minute", "her arm was still red and splotchy with raised areas that were hard to the touch", "she couldn't raise her arm", "arm was still hurting at injection site and sore", "she got an MRI done which showed mild suprapinatus tendinosis", "diagnosed her with shoulder injury related to vaccine administration"; moderna covid-19 vaccine (Dose Number: 2, Manufacturer: Moderna, Lot number: Unknown, Dose: 0.5 mL), administration date: 17Feb2021, for Covid-19 Immunization; moderna covid-19 vaccine (Dose Number: 1, Manufacturer: Moderna, Lot number: Unknown, Dose: 0.5 mL, Route: Intramuscular), administration date: 17Jan2021, for Covid-19 Immunization. The following information was reported: IMMUNISATION REACTION (non-serious), outcome "unknown", described as "mild symptoms"; VACCINATION SITE BRUISING (non-serious), outcome "unknown", described as "bruising at the injection site"; PYREXIA (non-serious), outcome "unknown", described as "fever of 100.0 °F"; RASH MACULAR (non-serious), outcome "unknown", described as "She did get the pink splotches again, but it wasn't bad". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : 150102 Moderna.